We are live on ! Find out more
STLNW

Starling Oncology, Inc. Warrant
STLNW

14 hedge funds and large institutions have $19.2K invested in Starling Oncology, Inc. Warrant in 2024 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 6 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

1.33% more ownership

Funds ownership: 3.44% → 4.78% (+1.3%)

7% less funds holding

Funds holding: 15 → 14 (-1)

50% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 2

63% less capital invested

Capital invested by funds: $52K → $19.2K (-$32.8K)

83% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 6

Holders
14
Holders Change
-1
Holders Change %
-6.67%
% of All Funds
0.18%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
6
Closed
2
Calls
$1K
Puts
–
Net Calls
+$1K
Net Calls Change
-$34K

Top Buyers

Rank Fund Capital Flow
1
LP
LMR Partners
United Kingdom
+$25.3K
2
AGM
Alpine Global Management
New York
+$390

Top Sellers

Rank Fund Capital Flow
1
Walleye Capital
Walleye Capital
New York
-$5.3K
2
FL
FreeGulliver LLC
Louisiana
-$2.72K
3
Two Sigma Investments
Two Sigma Investments
New York
-$600
4
Citadel Advisors
Citadel Advisors
Florida
-$85
5
UBS Group
UBS Group
Switzerland
-$46
Name Holding Trade Value Shares
Change 		Change in
Stake
LP
1
LMR Partners
United Kingdom
$8.45K +$25.3K +1,624,856 New
DM
2
Deerfield Management
New York
$6.5K – – –
DKCM
3
Davidson Kempner Capital Management
New York
$1.66K – – –
Man Group
4
Man Group
United Kingdom
$622 – – –
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
5
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
$613 – – –
WAM
6
Wolverine Asset Management
Illinois
$388 – – –
AGM
7
Alpine Global Management
New York
$350 +$390 +25,024 +100%
Walleye Capital
8
Walleye Capital
New York
$280 -$5.3K -339,643 -86%
TCM
9
Tenor Capital Management
New York
$130 – – –
FL
10
FreeGulliver LLC
Louisiana
$96 -$2.72K -174,601 -90%
Citadel Advisors
11
Citadel Advisors
Florida
$87 -$85 -5,425 -30%
UBS Group
12
UBS Group
Switzerland
$16 -$46 -2,977 -49%
CS
13
Clear Street
New York
$8 -$4 -265 -14%
Bank of America
14
Bank of America
North Carolina
$1 -$5 -299 -60%
CAC
15
Cowen and Company
New York
– -$1.73K -86,726 Closed
Two Sigma Investments
16
Two Sigma Investments
New York
– -$600 -30,000 Closed

STLNW Hedge Fund Activity: Q4 2024 in Review

14 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Starling Oncology, Inc. Warrant (STLNW) for Q4 2024, worth a combined $19.2K — down 63% from $52K a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of STLNW and 1 opened new positions — a net loss of 1 holder — while 6 trimmed existing stakes and 1 added.

The largest buyer was LMR Partners, opening a new position worth an estimated $25.3K. The largest seller was Walleye Capital, cutting an estimated $5.3K.

  • 14 institutional investors held Starling Oncology, Inc. Warrant (STLNW) as of Q4 2024, down from 15 in Q3 2024.
  • Funds reported $19.2K of Starling Oncology, Inc. Warrant stock for Q4 2024, down 63% quarter-over-quarter.
  • 1 fund opened new Starling Oncology, Inc. Warrant positions in Q4 2024 and 2 closed out, a net change of -1 holder.
  • The largest Starling Oncology, Inc. Warrant buyer in Q4 2024 was LMR Partners, an estimated $25.3K added.
  • The largest Starling Oncology, Inc. Warrant seller in Q4 2024 was Walleye Capital, an estimated $5.3K sold.

Based on aggregated 13F filings for Q4 2024.